Su-Yeon Nam

President chez GI INNOVATION, INC. Fortune : 12 M $ au 30/04/2024

Profil

Su-Yeon Nam is currently the Chief Executive Officer at Ints Bio Co. Ltd.
and the Co-President, Director & Head-Overseas Sales at GI Innovation, Inc. Previously, Dr. Nam worked as the Head-Medical Director at Bristol Myers Squibb Co. in 2011, as the MD & Head-Chung Ang Research Institute at Yuhan Corp.
from 2014 to 2016, and as the Head-Medical Department at Bristol-Myers Squibb (Singapore) Pte Ltd.
Dr. Nam obtained a doctorate degree from Yonsei University in 2001.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
GI INNOVATION, INC. 2,80%	19/04/2024	1 235 122 ( 2,80% )	12 M $	30/04/2024

Postes actifs de Su-Yeon Nam

Sociétés	Poste	Début
GI INNOVATION, INC.	President	01/12/2018
Ints Bio Co. Ltd.	Chief Executive Officer	-

Anciens postes connus de Su-Yeon Nam

Sociétés	Poste	Fin
YUHAN CORPORATION	Chief Tech/Sci/R&D Officer	31/12/2016
Bristol-Myers Squibb (Singapore) Pte Ltd.	Corporate Officer/Principal	-
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	-

Formation de Su-Yeon Nam

Yonsei University

Doctorate Degree